Inhibition of GSK-3 beta activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in breast cancer
| dc.creator | Steelman, Linda S. | |
| dc.creator | Davis, Nicole M. | |
| dc.creator | Sokolosky, Melissa | |
| dc.creator | Abrams, Stephen L. | |
| dc.creator | Martelli, Alberto M. | |
| dc.creator | Nicoletti, Ferdinando | |
| dc.creator | Fagone, Paolo | |
| dc.creator | Mazzarino, Clorinda | |
| dc.creator | Malponte, Graziella | |
| dc.creator | Libra, Massimo | |
| dc.creator | Cervello, Melchiorre | |
| dc.creator | Montalto, Giuseppe | |
| dc.creator | Maksimović-Ivanić, Danijela | |
| dc.creator | Mijatović, Sanja | |
| dc.creator | Umezawa, Kazuo | |
| dc.creator | McCubrey, James A. | |
| dc.date.accessioned | 2016-05-23T11:00:44Z | |
| dc.date.available | 2016-05-23T11:00:44Z | |
| dc.date.issued | 2014 | |
| dc.identifier.issn | 1791-244X | |
| dc.identifier.uri | https://radar.ibiss.bg.ac.rs/handle/123456789/2278 | |
| dc.language | English | |
| dc.rights | restrictedAccess | |
| dc.source | International Journal of Molecular Medicine | |
| dc.title | Inhibition of GSK-3 beta activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in breast cancer | en |
| dc.type | conferenceObject | |
| dc.rights.license | ARR | |
| dcterms.abstract | Максимовић, Данијела Д.; Мијатовић, Сања А.; Стеелман, Линда С.; Давис, Ницоле М.; Соколоскy, Мелисса; Абрамс, Степхен Л.; Мартелли, Алберто М.; Ницолетти, Фердинандо; Фагоне, Паоло; Маззарино, Цлоринда; Малпонте, Гразиелла; Либра, Массимо; Цервелло, Мелцхиорре; Монталто, Гиусеппе; Умезаwа, Казуо; МцЦубреy, Јамес А. | |
| dc.citation.issue | 1 | |
| dc.citation.volume | 34 | |
| dc.identifier.wos | 000341276000083 | |
| dc.type.version | publishedVersion | en |
| dc.identifier.rcub | https://hdl.handle.net/21.15107/rcub_ibiss_2278 |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||